Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization
ConclusionsUS patients with T2D who experienced hypoglycemia within 6 months of basal insulin initiation were more likely to discontinue treatment, accompanied by a greater healthcare burden.FundingSanofi US, Inc.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Healthcare Costs | Insulin | Study | USA Health